Analytic for Hemodynamic Instability (AHI)

The Analytic for Hemodynamic Instability (AHI) is a software system designed for early shock detection by continuously analyzing ECG and blood pressure data against predefined critical thresholds. Through retrospective validation, AHI has demonstrated its potential to alert clinicians to impending hypotensive events, aiming to facilitate prompt interventions and improve patient outcomes in critical care settings.

The Analytic for Hemodynamic Instability (AHI) system is engineered to monitor hospitalized patients by continuously analyzing their electrocardiogram (ECG Lead II) and blood pressure measurements. Its core purpose is the early detection of shock, which it identifies when a patient's heart rate reaches or exceeds 100 beats per minute concurrently with either a systolic blood pressure below 90 mmHg or a mean arterial pressure below 70 mmHg. The system processes this physiological data in sliding windows, triggering an alert to clinicians upon recognizing this predefined critical pattern indicative of hemodynamic compromise. Operating as a software adjunct, AHI's efficacy has been assessed through retrospective validation using intensive care unit (ICU) datasets. These studies have shown its capability to issue alerts either simultaneously with or, crucially, preceding the clinical manifestation of hypotensive events. By providing this early warning, the AHI system aims to empower clinicians with the foresight to initiate timely, preemptive interventions, thereby potentially improving patient outcomes by mitigating the progression of hemodynamic instability.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What is the typical lead time the AHI system provides before a clinically overt hypotensive event, and how does this vary across different patient populations or shock etiologies?; What were the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of AHI in the retrospective ICU validation, and what were the criteria for defining a 'true positive' alert?; How does the AHI algorithm differentiate between transient, clinically insignificant physiological fluctuations and genuine precursors to hemodynamic collapse?; Are there plans to integrate AHI with electronic health records for automated data input or to incorporate other data streams (e.g., lab values, medication administration) to enhance its predictive accuracy?; What impact has AHI demonstrated on clinical workflow, clinician response times, and ultimately, patient outcomes in prospective studies or real-world deployments beyond retrospective validation?